Tobramycin

Back to search

Molecule Structure

Scientific Name

Tobramycin

Description of the Drug

Tobramycin is an aminoglycoside antibiotic used to treat cystic fibrosis-associated bacterial, lower respiratory tract, urinary tract, eye, skin, bone, and skin structure infections.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00684

Brand Name(s)

Aktob, Bethkis, Bramitob, Kitabis pak, Nebcin, Nebicin, Nebramycin, Nebris, Obramycin, Tobi, Tobi podhaler, Tobradex, Tobradex St, Tobralex, Tobramycin, Tobravisc, Tobrex, Tymbrineb, Vantobra

Company Owner(s)

Igi Laboratories Inc, Alkem Laboratories Ltd, Watson Laboratories Inc, Bausch And Lomb Pharmaceuticals Inc, Luoxin Aurovitas Pharma Chengdu Co Ltd, Dr Reddys Laboratories Sa, Xellia Pharmaceuticals Aps, Xgen Pharmaceuticals Djb Inc, Amneal Eu Ltd, Novartis Pharmaceuticals Corp

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
70S ribosome PROTEIN NUCLEIC-ACID COMPLEX INHIBITOR CHEMBL2364022

Unichem Links

SureChEMBL SCHEMBL2838
PharmGKB PA451704
Human Metabolome Database HMDB0014822
DrugBank DB00684
PubChem: Thomson Pharma 14760717 14931869
PubChem 36294
NMRShiftDB 60027632
LINCS LSM-6534
Nikkaji J4.533K
PDBe TOY
BindingDB 50366778
EPA CompTox Dashboard DTXSID8023680
DrugCentral 2684
Metabolights MTBLC28864
Brenda 107369 51945 94477 939 107368
ChemicalBook CB7154445
Guide to Pharmacology 10930
rxnorm TOBRAMYCIN SULFATE TOBI TOBRAMYCIN TOBREX BETHKIS
KEGG Ligand C00397
ChEBI 28864
ZINC ZINC000008214692